Vincent Hingot

Vincent Hingot serves as President of the Drug Substance Division at Thermo Fisher Scientific since June 2022, focusing on financial and market performance through strategic leadership. Previously, Hingot held significant roles at Sanofi Pasteur, including Senior Vice President of Global Industrial Operations Manufacturing and Supply, managing the production of over one billion vaccine doses annually across a global network of sites. Hingot's extensive experience in industrial operations also includes a tenure at GlaxoSmithKline Biologicals, where responsibilities ranged from Vice President of Industrial Operations to Site Director, contributing to vaccine production efficiency and process optimization. Hingot holds a Master of Engineering in Biotechnology from Meurice Chimie and further education in management at EPM Formation.